Management Team

  • Leo LUO
    Founder and Managing Director of the Company as well as the Founding Partner of China "Pharma and MedTech BD Alliance" & Innovation Center. Leo has 23 years of experiences of the international business development in the pharmaceutical industry, and as the project leader he once managed more than 10 global transaction deals with the models of IP license-in, JV, distribution rights granting as well as overseas investment. Before founding Angine, Leo once was the Global Head and Director of International Business Development oftwo Pharmaceutical public companies in China, as well as the head of Academic Exchange as well as International Affairs during the 1stGlobal Health Forum (GHF) of Boao Forum for Asia in 2019. Besides the position in Angine,Leo also serves as Executive Director of Internationalization Working Committee of China Pharmaceutical Enterprise Association (CPEA). Leo graduated from Peking Universityand obtained the Master Degree (M.E) of Pharmaceutical Engineering.
  • Phonix HE
    Board Director and Venture Partner of Angine Bio. With the Chemical and Biologicaleducation background, Phoenix HE has more than 20 years international BDworking experiences in the companies like Fosun Pharma, Shanghai Pharma, AAIChina and Sancilio & Co., Inc. Phoenix once participated more than 10 global BDtransaction projects as the key member in the past 20 years and she has the deepExperiences for the overseas healthcare products’licensing-in particularly for thelaunched products as well as the 505b2 products.
  • Lily LEI
    Venture Partner of Angine.With 27 years of experience on international business in Pharmaceutical industry projects, Lilyhas assistedmore than 50 Chinese companies to export the drug products to more than 20 countries. Lily has rich experiences in drug product and medical devices’regulatory affairs and registration as well as related business terms.Lily graduated from Peking Universityand obtained the master degree of Pharmaceutical Engineering.
  • Xielong LUO
    Company Expert Committee Head.With more than 40years academic and business management experiences in the pharmaceutical industry, Mr. Xielong Luo is a veteran of drug research & development, pharma international collaboration, China market access policy as well as new business funding and investment. Mr. Luo once was the Executive Director of Global Health Forum (GHF) of Boao Forum of Asia (BAF), a international exchanges platform for China and overseas in term of the health care and health economy. He is also the Director of Internationalization Working Committee of China Pharmaceutical Enterprise Association (CPEA),Director of Internationalization WorkingCommittee China OTC Association andDirector of Zhejiang Yangtze Delta Region Biomedical Research and Development Center. Mr. Luo was educated in China and US with the clinical medicine background.